论文部分内容阅读
目的:探讨胺碘酮治疗心力衰竭合并心律失常的临床疗效。方法:选取我院在2014年12月-2016年8月收治的94例心力衰竭合并心律失常患者,将其随机分为参照组与研究组各47例,参照组患者给予心力衰竭与心律失常的常规治疗,研究组在参照组治疗基础上再使用胺碘酮进行治疗,对两组患者取得的临床疗效进行观察并比较。结果:研究组患者取得的治疗总有效率明显高于参照组,P<0.05。结论:对心力衰竭合并心律失常患者在常规治疗的基础上再给予胺碘酮治疗能够取得更加显著的临床疗效,大大改善了患者的治疗效果,使患者的病情得到了有效的恢复,值得在今后予以推广和应用。
Objective: To investigate the clinical efficacy of amiodarone in the treatment of heart failure with arrhythmia. Methods: A total of 94 patients with heart failure and arrhythmia admitted in our hospital from December 2014 to August 2016 were randomly divided into reference group (n = 47) and study group (n = 47). Patients in reference group were given heart failure and arrhythmia Routine treatment, the study group in the reference group based on the use of amiodarone treatment, the clinical efficacy of the two groups were observed and compared. Results: The total effective rate of the treatment group was significantly higher than that of the reference group (P <0.05). Conclusion: In the patients with heart failure and arrhythmia, routine treatment of amiodarone given on the basis of conventional treatment can achieve more significant clinical efficacy, greatly improving the therapeutic effect of patients, so that the patient’s condition has been effectively restored, it is worth in the future To promote and apply.